MDT

100.04

+0.6%↑

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

MDT

100.04

+0.6%↑

147.78

+0.47%↑

VEEV

236.71

+1.49%↑

HQY

96.5

+3.42%↑

PHR.US

17.45

+0.98%↑

Home・Lista de Ações・Co-Diagnostics Inc

Co-Diagnostics Inc

Fechado

SetorSaúde

5.66 -4.23

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.44

Máximo

5.96

Indicadores-chave
By Trading Economics
Rendimento	1.8M -5.9M
Vendas	-18K 145K
Margem de lucro	-4,049.266
Funcionários	132
EBITDA	1M -6.7M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	-73.68% downside

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	12M
Abertura anterior	9.89
Fecho anterior	5.66

Sentimento de Notícias

By Acuity

31%

69%

80 / 373 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

0.3495 / 0.3699 Suporte e Resistência

Co-Diagnostics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de jan. de 2026, 21:14 UTC

Grandes Movimentos do Mercado

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 de jan. de 2026, 19:23 UTC

Aquisições, Fusões, Aquisições de Empresas

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 de jan. de 2026, 17:41 UTC

Grandes Movimentos do Mercado

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 de jan. de 2026, 15:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Advent International Leads InPost Takeover Offer, Sky News Says

6 de jan. de 2026, 15:37 UTC

Grandes Movimentos do Mercado

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record High -- Market Talk

6 de jan. de 2026, 23:35 UTC

Conversa de Mercado

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 de jan. de 2026, 23:19 UTC

Conversa de Mercado

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 de jan. de 2026, 22:53 UTC

Conversa de Mercado

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 de jan. de 2026, 22:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 de jan. de 2026, 22:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de jan. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de jan. de 2026, 21:12 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

6 de jan. de 2026, 21:12 UTC

Conversa de Mercado

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 de jan. de 2026, 20:59 UTC

Grandes Movimentos do Mercado

Aquisições, Fusões, Aquisições de Empresas

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 de jan. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 de jan. de 2026, 20:01 UTC

Conversa de Mercado

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 de jan. de 2026, 19:52 UTC

Conversa de Mercado

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 de jan. de 2026, 19:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 de jan. de 2026, 19:08 UTC

Aquisições, Fusões, Aquisições de Empresas

OneStream to Go Private Through $6.4B Hg Acquisition

6 de jan. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Ganhos

Financial Services Roundup: Market Talk

6 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

6 de jan. de 2026, 15:57 UTC

Conversa de Mercado

Crude Futures Ease Back From Early Gains -- Market Talk

6 de jan. de 2026, 15:34 UTC

Conversa de Mercado

Ganhos

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 de jan. de 2026, 15:27 UTC

Conversa de Mercado

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Comparação entre Pares

Variação de preço

Co-Diagnostics Inc Previsão

Preço-alvo

By TipRanks

-73.68% parte inferior

Previsão para 12 meses

Média 1.5 USD -73.68%

Máximo 1.5 USD

Mínimo 1.5 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Co-Diagnostics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

Comprar

Manter

Vender

Com base em 2 analistas que deram avaliações de ações para Co-Diagnostics Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

0.3495 / 0.3699Suporte e Resistência

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Sentimento

By Acuity

80 / 373 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.